Prevalence of Extended-Spectrum Beta Lactamase-Producing Microorganisms in Dr. Mohammad Hoesin Hospital Palembang
DOI:
https://doi.org/10.24293/ijcpml.v28i3.1897Keywords:
Extended-spectrum beta lactamase, Klebsiella pneumoniae, EnterobacteriaceaeAbstract
Production of Extended-Spectrum Beta-Lactamase (ESBL) by Enterobacteriaceae continues to be a problem of infectious diseases, especially in hospitals. The main causes of ESBL-producing bacteria colonization are urinary tract infections, length of hospital stay, invasive medical equipment, and antibiotics usage. This study aims to compare the incidence of ESBL based on the type of organism in Dr. Mohammad Hoesin Hospital for the 2017 and 2018 periods. The research design used was descriptive with a cross-sectional approach, which used secondary data at the Clinical Pathology Department of Dr. RSUP. Mohammad Hoesin Palembang. The findings of this study showed a decreasing pattern in the incidence of ESBL in 2017 and 2018, but with a similar pattern which was dominated by Klebsiella pneumoniae (followed by Escherichia coli and Klebsiella ozaenae), inpatients in pediatric wards, internal medicine, and intensive care units, and on sputum specimens. This study showed the presence of high levels of ESBL-producing bacteria (>60%) in Dr. Mohammad Hoesin Hospital, which was mainly caused by Klebsiella pneumoniae.
Downloads
References
Nasution H, Jusuf H, Ramadhani E, Husein I. Model of spread of infectious disease. Syst Rev Pharm, 2020; 11(2): 685-9.
Taxifulati Y, Wushouer H, Fu M, Zhou Y, Du K, et al. Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015-2018. BMC Health Serv Res, 2021; 21(1): 832.
Akbar MT, Shah H, Faisal S, Abdulla SSA, Jan F. Irrational use of antibiotics and associated health risks
in District Charsadda, Pakistan. J Trop Dis Public Heal, 2020; 8: 353.
Nasution A, Fashilah N, Nugraha SE. Appropriateness of antibiotic utilization in hospitalized post-surgery patients. Indones J Pharm Clin Res. 2019; 2(1): 37-44.
Richardson LA. Understanding and overcoming antibiotic resistance. PLoS Biol, 2017; 15(8): e2003775.
Horie H, Ito I, Konishi S, Yamamoto Y, Yamamoto Y, et al. Isolation of ESBL-producing bacteria from
sputum in community-acquired pneumonia or healthcare-associated pneumonia does not indicate
the need for antibiotics with activity against this class. Intern Med, 2018; 57(4): 487-95.
Donkor ES, Codjoe FS. Methicillin resistant staphylococcus aureus and extended-spectrum beta
lactamase producing enterobacteriaceae: A therapeutic challenge in the 21 century. Open Microbiol J, 2019; 13: 94-100.
Bush K. Past and present perspectives on β-lactamases. Antimicrob Agents Chemother, 2018; 62(10): e01076-18.
Akpaka PE, Vaillant A, Wilson C, Jayaratne P. Extended-Spectrum Beta Lactamase (ESBL) produced
by Gram-negative bacteria in Trinidad and Tobago. Int J Microbiol, 2021; 2021: 5582755.
Janda JM, Abbott SL. The changing face of the family Enterobacteriaceae (order: "Enterobacterales"): new members, taxonomic issues, geographic expansion, and new diseases and disease syndromes. Clin
Microbiol Rev, 2021; 34(2): e00174-20.
Nazmi M, Mahardik NMA, Gunardi WD. Kejadian infeksi saluran kemih oleh bakteri Escherichia coli dan Klebsiella pneumoniae extended-spectrum beta lactamase: Studi kasus di rumah sakit swasta periode 2012-2015. J Kedokt Meditek, 2017; 23(62): 54-62.
Toptan H, Balköse G, DoÄŸan í–, Adaleti R, Aksaray S. Detection of the presence of extended-spectrum beta lactamase enzyme in Gram-negative bacteria according to CLSI and EUCAST criteria. Haydarpasa Numune Med J, 2020; 60(4): 352-6.
Abayneh M, Tesfaw G, Abdissa A. Isolation of Extended-Spectrum β lactamase- (ESBL-) producing
Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol, 2018; 2018: 4846159.
Hamid F, Munawir M, Amaruddin AI, Hapsari BK, Sultan AR, Amiruddin D. Prevalence of fecal carriage of extended-spectrum β lactamase-producing Enterobacteriaceae among school children in South Sulawesi, Indonesia. Arch Clin Infect Dis, 2020; 15(2): e96945.
Senbayrak S, Serkan Boz E, Cevan S, Inan A, Ozturk Engin D, et al. Antibiotic resistance trends and the ESBL prevalence of Escherichia coli and Klebsiella spp. urinary isolates in-and outpatients in a tertiary care hospital in Istanbul, 2004-2012. Jundishapur J Microbiol, 2017; 10(5): e13098.
Yamaguchi H, Takuma A, Fukuoka E, Nakamura H, Suzuki K, et al. Significant increase of Extended-Spectrum Beta Lactamase (ESBL) producing bacteria prevalence in a Japanese University Hospital. Int J Infect Dis, 2018; 73: 125.
McDanel J, Schweizer M, Crabb V, Nelson R, Samore M, et al. Incidence of Extended-Spectrum β Lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: A systematic literature review. Infect Control Hosp Epidemiol, 2017; 38(10): 1209-15.
FarajzadehSheikh A, Veisi H, Shahin M, Getso M, Farahani A. Frequency of quinolone resistance genes among Extended-Spectrum β lactamase (ESBL)-producing Escherichia coli strains isolated from urinary tract infections. Trop Med Health. 2019; 47(1): 1-7.
Joshi M, Kaur S, Kaur HP, Mishra T. Nosocomial infection: Source and prevention. Int J Pharm Sci Res,
; 10: 1613-24.
Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, et al. High rates of multidrug-resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control, 2017; 6(1): 1-7.
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, et al. Antibiotic resistance: A rundown of a global crisis. Infect Drug Resist, 2018; 11: 1645.
Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: From microbial ecology to public policy. Microorganisms, 2019; 7(6): 180.
Hayati Z, Rizal S, Putri R. Isolation of Extended-Spectrum β Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumiae from Dr. Zainoel Abidin General Hospital, Aceh. Int J Trop Vet Biomed Res, 2019; 4(1): 16-22.
Khalifa SM, Abd El-Aziz AM, Hassan R, Abdelmegeed ES. β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E.coli and K.pneumoniae. PLoS One, 2021; 16(5): e0251594.
Aaftab GP, Patil AB, Medegar S. Multivariate analysis of risk factors for ESBL and AmpC producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Karnataka: A case control study. Indian J Microbiol Res, 2018; 5(1): 1-6.
Husada S, Hardjowijoto S, Kuntaman K, JP W, Gardjito W. Perbandingan dan penyebaran Escherichia coli dan Klebsiella pneumoniae penghasil extended-spectrum beta laktamase pada isolat urine pasien pria dengan kateter dan tanpa kateter. Indones J Urol, 2018; 15(1): 15-20.
Setiawan S, Widyati PH, Harijono P. Profil penggunaan antibiotik pascapencanangan penerapan program pengendalian resistensi antibiotik di intensive care unit Rumah Sakit TNI-AL dr. Ramelan Surabaya. Indones J Clin Pharm, 2018; 7(1): 30-7.
Winarni W, Yasin NM, Andayani TM. Pengaruh program pengendalian resistensi antimikroba
terhadap penggunaan antibiotik profilaksis pada bedah obstetri dan ginekologi. J Manaj dan Pelayanan
Farm, 2018; 10(2): 145-55. 29. Akinlabi A, Oluwadun A, Alli OAT, Oluremi AS, Webber MA, Ogbolu DO. Role of extended spectrum beta lactamases in Cephalosporin and Carbapenem resistance in Escherichia coli from inpatients and outpatients in Nigeria. J Clin Diagnostic Res, 2020; 14(2): DC10-5.
Legese MH, Asrat D, Aseffa A, Hasan B, Mihret A, Swedberg G. Molecular epidemiology of extended-spectrum beta-lactamase and AmpC producing Enterobacteriaceae among sepsis patients in Ethiopia: A prospective multicenter study. Antibiotics, 2022; 11(2): 131.
Lerminiaux NA, Cameron ADS. Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol, 2019; 65(1): 34-44.
Hu YJ, Ogyu A, Cowling BJ, Fukuda K, Pang HH. Available evidence of antibiotic resistance from
extended-spectrum β lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: A systematic review and meta-analysis. Bull World Health Organ, 2019; 97(7): 486-501B.
Suranadi W, Fatmawati D, Ryalino C, Hartawan IGAGU, Yanto F. The influence of antibiotics usage on
extended-spectrum β lactamase-producing Enterobacter colonization among intensive care unit patients. Open Access Maced J Med Sci, 2021; 9(A): 52-6.
Khadijah S, Handayani I, Sennang N. Prevalence and characteristic multidrug-resistant organisms in
intensive care unit of Dr. Wahidin Sudirohusodo Hospital Makassar. Indones J Clin Pathol Med Lab, 2019; 25(3): 323-7.
Anggraini D, Sholihin UH, Savira M, Djojosugito FA, Irawan D, Rustam RP. Prevalensi dan pola sensitivitas Enterobacteriaceae penghasil ESBL di RSUD Arifin Achmad Pekanbaru. J Kedokt Brawijaya, 2018; 30(1): 47-52.
Parajuli NP, Maharjan P, Joshi G, Khanal PR. Emerging perils of extended spectrum β lactamase producing Enterobacteriaceae clinical isolates in a teaching hospital of Nepal. Biomed Res Int, 2016; 2016: 1782835.
Paul S, Jhora ST, Dey PP, Begum BA. Detection of Extended-Spectrum Beta lactamase (ESBL) producing Gram-negative bacteria from clinical specimens of Sir Salimullah Medical College and Mitford Hospital. Bangladesh J Med Microbiol, 2016; 10(1): 8-12.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
